VeriSee AMD is an AI-assisted screening software for age-related macular degeneration (AMD) that identifies high-risk AMD patients. Its core AI model has been trained from images labeled by retina specialists, and the software has been validated in a pivotal clinical trial against rigorous clinical reference standard. In addition, the software can be run on a device without network connection.

1. The first AI Software as a Medical Device (SaMD) for AMD approved by Taiwan FDA
2. Indicated for adults over 50 years old
3. No ophthalmologist required
4. Quick screening for high-risk cases